Evidence map›Paper›PMID 30524964›Full record

ArticleFrontiers in oncology2018

Genome-Wide Profiling of Prognostic Alternative Splicing Signature in Colorectal Cancer.

Zhen Zong, Hui Li, Chenghao Yi, Houqun Ying, Zhengming Zhu, He Wang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Identification of prognostic alternative splicing signature in gastric cancer.Archives of public health = Archives belges de sante publique · 2022
    Article
  10. Article
  11. The Role of Autophagy in Tumor Immune Infiltration in Colorectal Cancer.Analytical cellular pathology (Amsterdam) · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Alternative splicing of lncRNAs in human diseases.American journal of cancer research · 2021
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Zhen ZongDepartment of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Hui LiDepartment of Rheumatology, The first Affiliated Hospital of Nanchang University, Nanchang, China.
Chenghao YiDepartment of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Houqun YingDepartment of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University (Jiangxi Province Key Laboratory of Laboratory Medicine), Nanchang, China.
Zhengming ZhuDepartment of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
He WangDepartment of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Nanchang University · CNSecond Affiliated Hospital of Nanchang University · CNFirst Affiliated Hospital of Nanchang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

alternative splicingcolorectal cancerprognosissplicing factorsurvival

Identifiers

PMID30524964
PMCPMC6262947
OpenAlexW2901482817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.